| Future Health Pharma GmbH - Insadol, Filmtabletten | | 68497 | | 01 | | Insadol | | Filmtabletten | | A01A | | STOMATOLOGIKA | | 18.01.2024 | | |
| | Zusammensetzung | | Maydis olei fractionis nonsaponificabilis extractum (Zea mays L., embryo) 35.0 mg, Auszugsmittel ethylis acetas, cellulosum microcristallinum, lactosum monohydricum 122.0 mg, silica colloidalis anhydrica, povidonum K 30, carboxymethylamylum natricum A, magnesii stearas, hypromellosum, titanii dioxidum, ethylcellulosum, diethylis phthalas, poly(alcohol vinylicus), talcum, E 102 1.10 mg, E 110 0.17 mg, lecithinum, xanthani gummi, E 132, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, natrii hydrogenocarbonas, silica colloidalis anhydrica, natrii laurilsulfas, carmellosum natricum, maltodextrinum, glucosum monohydricum 0.31 mg, natrii citras dihydricus, pro compresso obducto, corresp. natrium 0.181-0.265 mg. | | Packungsbestandteile | | Filmtabletten | | | | Wirkstoffe | Stärke |
|---|
| Maydis olei Fractionis Nonsaponificabilis Extractum (Zea mays l., Embryo) | 35 mg |
| | | | Hilfsstoffe | Stärke | Zusätzliche Information |
|---|
| Acidi Methacrylici | | | | Auszugsmittel Ethylis Acetas | | | | Carboxymethylamylum Natricum A | | | | Carmellose Natrium | | | | Cellulosum Microcristallinum | | | | Diethylis Phthalas | | | | E 102 | 1.1 mg | color. | | E 110 | 0.17 mg | color. | | E 132 | | color. | | Ethylcellulosum | | | | Ethylis Acrylatis Polymerisatum | | | | Glucose Monohydrat | 0.31 mg | | | Hypromellosum | | | | Lactose Monohydrat | 122 mg | | | Lecithin | | | | Magnesii Stearas | | | | Maltodextrin | | | | Natrii Citras Dihydricus | | | | Natrium Hydrogencarbonat | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | | | Titanium Dioxid | | | | Triethylis Citras | | | | Xanthani Gummi | | |
|
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 001 | 100 | PA | PA | D | | Nein |
|
|
